About Tim Carroll

The Snake Bite Program owned by Aishah Pelley who works with consultant Tim Carrol. Tim has extensive experience working with, researching and understanding snake venom genotypes from around the world.

Tim Carroll is a business consultant in the Snake Bite Program with Aishah. He has extensive experience working in the production of snake antivenom, international exports scientific advisory and more. Tim is extensively published for his work in snake bite detection and medical science.

Tim’s qualifications include:

Bsc. MLS -Medical Science, Queensland University of Technology, 1982 – 1986.
Executive Consortium Program, Business Management - AGSM, 2005
Professional Negotiating and Influencing -ENS International
Global Trade – The Glo Project, 2019.

Tim’s work experience is extensive and includes:

Director of International Market Development – Halley Assist, 2019 – Present.
Founder & Director – The Glow Project, 2018 – Present.
Healthcare Industry Advisory Board Member – Eureka Technology Innovation & Investment, 2019 – Present.
Scientific Advisor – EcoFuture Pty Ltd, 2020 – Present
Director of Technology (Contract) – Australia-China Health Accelerator, 2018 – Present.
Programme Director – Australia-China Association Of Scientists and Entrepreneurs (ACASE), 2018 – 2019
State Director Victoria & Tasmania & National Lead – Health Science and Technology – Austrade, 2016 – 2018
Director – Tim Carroll Consulting, 2016
Commercial Director – Diagnostic Solutions, 2015 – 2016
Manager of Innovation and Commercial Development – La Trobe University, 2013 – 2015
Director – Globin Global, 2010 – 2013
Technical Director – CSL, 2008 – 2010
Director of International Market Development – CSL, 2006 – 2008
Business Manager – Immunohaematology Business Unit, 2002 – 2006
Technical Marketing Manager- Immunohaematology, 1998 – 2002.

PUBLICATIONS

Tim has multiple publications including:

IMMUNOHEMATOLOGY: Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells - Transfusion 02/2010; 50(3):635 - 641. · Feb 1, 2010
The molecular basis of cross-reactivity in the Australian Snake Venom Detection Kit (SVDK) - Toxicon 01/2008; 50(8):1041-52 · Jan 1, 2008
Synthetic glycolipid modification of red blood cell membranes - Transfusion 06/2007; 47(5):876-82 · Jun 1, 2007
Cardiovascular, haematological and neurological effects of the venom of the Papua New Guinean small-eyed snake (Micropechis ikaheka) and their neutralisation with CSL polyvalent and black snake antivenoms - Toxicon 12/2003; 42(6):647-55 · Dec 1, 2003
Black snake, brown snake or mistake? A cautionary tale. - Australian family physician 10/2001; 30(9):832 · Oct 1, 2001
& More Joint publications.

As the former technical director of CSL, Tim is a valuable member of The Snake Bite Program

Tim's Goals

To genotype snake venoms in an advanced quality controlled system

To promote awareness and understanding of snakes & reptiles leading to a reduction in snake bite incidents

Development of modern effective snake bite bandages that can be used globally.